Hematolymphoid malignancies diagnosed at the time of radical prostatectomy

Journal of Urology

Volumn 158, Issue 4, 1997, Pages 1457-1459

  Terris, Martha K ^a   Hausdorff, John ^b   Freiha, Fuad S ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Leukemia; Lymphoma; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN TISSUE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030880578     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64242-3     Document Type: Article

References (23)

1. Donohue, R. E.: Second malignancies in adenocarcinoma of the prostate. Sixth International Prostate Cancer Update, Beaver Creek, Colorado, February 3, 1996.
2. Donohue, R. E.: Causes of death in a radical prostatectomy series. Sixth International Prostate Cancer Update, Beaver Creek, Colorado, February 3, 1996.
3. Longo, D. L., DeVita, V. T., Jr., Jaffe, E. S., Mauch, P. and Urba, W. J.: Lymphocytic lymphomas. In: Cancer: Principles and Practice of Oncology, 4th ed. Edited by V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott Company, chapt. 52, pp. 1859-1927, 1993.
4. Deisseroth, A. B., Andreeff, M., Champlin, R., Keating, M. J., Kantarjian, H., Khouri, I. F. and Talpaz, M.: Chronic leukemias. In: Cancer: Principles and Practice of Oncology, 4th ed. Edited by V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott Company, chapt. 55, pp. 1965-1983, 1993.
5. Rai, K. R. and Patel, D. V.: Chronic lymphoctic leukemia. In: Hematology: Basic Principles and Practice. Edited by R. Hoffman, E. J. Benz, Jr., S. Shattil, B. Furie, H. J. Cohen and L. E. Silberstein. New York: Churchill Livingstone, Inc., part VI, chapt. 83, pp. 1308-1321, 1995.
6. Rai, K. R., Sawitsky, A., Cronkite, E. P., Chanana, A. D., Levy, R. N. and Pasternack, B. S.: Clinical staging of chronic lymphocytic leukemia. Blood, 46: 219, 1975.
7. Montserrat, E. and Rozman, C.: Chronic lymphocytic leukaemia: prognostic factors and natural history. Baillieres Clin. Haematol., 6: 849, 1993.
8. Montserrat, E., Vinolas, N., Reverter, J. C. and Rozman, C.: Natural history of chronic lymphocytic leukaemia: on the progression and prognosis of early clinical stages. Nouv. Rev. Fr. Hematol., 30: 359, 1988.
9. Natural history of stage A chronic lymphocytic leukemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukemia. Brit. J. Haematol., 76: 45, 1990.
10. Frizzera, G.: Non-Hodgkin's lymphomas: pathologic features and clinical correlations. In: Hematology: Basic Principles and Practice., 2nd ed. Edited by R. Hoffman, E. J. Benz, Jr., S. Shattil, B. Furie, H. J. Cohen and L. E. Silberstein. New York: Churchill Livingstone, Inc., part VI, chapt. 80, pp. 1247-1277, 1995
11. Horning, S. J.: Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Sem. Oncol., suppl. 5, 20: 75, 1993.
12. Leonard, R. C., Hayward, R. L., Prescott, R. J. and Wang, J. X.: The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party. Ann. Oncol., 2: 655, 1991
13. DeVita, V. T., Jr., Hellman, S. and Jaffe, E. S.: Hodgkin's disease 'in: Cancer: Principles and Practice of Oncology, 4th ed. Edited by V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott Company, chapt. 51, pp. 1819-1858, 1993.
14. Glick, J. H. and Portlock, C. S.: Hodgkin's disease: clinical manifestations, staging and therapy. In: Hematology: Basic Principles and Practice. Edited by R. Hoffman, E. J. Benz, Jr., S. Shattil, B. Furie, H. J. Cohen and L. E. Silberstein. New York: Churchill Livingstone, Inc., part VI, chapt. 79, pp. 1226-1246, 19953
15. Hoppe, R. T., Coleman, C. N., Cox, R. S., Rosenberg, S. A. and Kaplan, H. S.: The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood, 59: 455, 1982.
16. Gospodarowicz, M. K., Sutcliffe, S. B., Bergsagel, D. E. and Chua T.: Radiation therapy in clinical stage I and II Hodgkin's disease. Eur. J. Cancer, 28A: 1841, 1992.
17. Longo, D. L., Young, R. C., Wesley, M., Hubbard, S. M., Duffey, P. L., Jaffe, E. S. and DeVita, V. T., Jr.: Twenty years of MOPP chemotherapy for Hodgkin's disease. J. Clin. Oncol., 4: 1295, 1986.
18. Prosnitz, L. R., Farber, L. R., Kapp, D. S., Scott, J., Bartino, J. R., Fischer, J. J. and Cadman, E. C.: Combined modality therapy for advanced Hodgkin's disease: 15 year follow up data. J. Clin. Oncol., 6: 603, 1988.
19. Saven, A. and Piro, L. D.: Hairy cell leukemia. In: Hematology: Basic Principles and Practice. Edited by R. Hoffman, E. J. Benz, Jr., S. Shattil, B. Furie, H. J. Cohen and L. E. Silberstein. New York: Churchill Livingstone, Inc., part VI, chapt. 84, pp. 1322-1331, 1995.
20. Keating, M. J., Estey, E. and Kantarjian, H.: Acute leukemia. In: Cancer: Principles and Practice of Oncology, 4th ed. Edited by V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott Company, chapt. 54, pp. 1938-1964, 1993.
21. Djavan, B., Keffer, J. H., Molberg, K. and Roehrborn, C. G.: False-positive serum prostate-specific antigen values in patient with non-Hodgkin's lymphoma of the kidney. Urology, 45: 875, 1995.
22. Horan, A. H. and Tarjoman, J.: Life-threatening leukopenia following flutamide during downstaging of a PSA false-positive lymphoma invading the prostate. Read at annual meeting of Western Section, American Urological Association, July 28, 1996, San Diego, California.
23. McDonnell, N. D. and Livingston, R. B.: Severe reversible neutropenia following treatment of prostate cancer with flutamide. J. Urol., 151: 1353, 1994.